Detalhe da pesquisa
1.
Other Primary Malignancies in Patients with Breast Cancer Who Undergo Germline Panel Testing.
Ann Surg Oncol
; 30(3): 1663-1668, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36094691
2.
Aromatase inhibitors and contralateral breast cancer in BRCA mutation carriers.
Breast Cancer Res Treat
; 196(1): 143-152, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36006499
3.
Contralateral Prophylactic Mastectomy among Women with Pathogenic Variants in BRCA1/2: Overall Survival, Racial, and Ethnic Differences.
Breast J
; 2022: 1447545, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36685664
4.
Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing.
Ann Surg Oncol
; 27(12): 4613-4621, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32720048
5.
Multigene panel testing results in patients with multiple breast cancer primaries.
Breast J
; 26(7): 1337-1342, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31999039
6.
Clinical outcome and toxicity from taxanes in breast cancer patients with BRCA1 and BRCA2 pathogenic germline mutations.
Breast J
; 26(8): 1572-1582, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32497289
7.
Elevated serum levels of sialyl Lewis X (sLeX) and inflammatory mediators in patients with breast cancer.
Breast Cancer Res Treat
; 176(3): 545-556, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31054033
8.
BRCA mutations in women with inflammatory breast cancer.
Cancer
; 124(3): 466-474, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29044548
9.
Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations.
Breast Cancer Res Treat
; 170(1): 101-109, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29470805
10.
Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer.
Breast Cancer Res Treat
; 158(1): 67-77, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27287781
11.
High incidence of germline BRCA mutation in patients with ER low-positive/PR low-positive/HER-2 neu negative tumors.
Cancer
; 121(19): 3422-7, 2015 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26280679
12.
Genotype-Phenotype Correlations by Ethnicity and Mutation Location in BRCA Mutation Carriers.
Breast J
; 21(3): 260-7, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25789811
13.
Predictors that influence contralateral prophylactic mastectomy election among women with ductal carcinoma in situ who were evaluated for BRCA genetic testing.
Ann Surg Oncol
; 21(11): 3466-72, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24796968
14.
Reply to Diagnosis of patients with inflammatory breast cancer is a problematic issue.
Cancer
; 124(4): 866, 2018 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29266209
15.
Genotype in BRCA-associated breast cancers.
Breast J
; 19(1): 87-91, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23231005
16.
Validating risk prediction models for multiple primaries and competing cancer outcomes in families with Li-Fraumeni syndrome using clinically ascertained data at a single institute.
medRxiv
; 2023 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37693464
17.
Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ.
Cancer
; 118(6): 1515-22, 2012 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22009639
18.
Earlier age of onset of BRCA mutation-related cancers in subsequent generations.
Cancer
; 118(2): 321-5, 2012 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21913181
19.
Early onset HER2-positive breast cancer is associated with germline TP53 mutations.
Cancer
; 118(4): 908-13, 2012 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21761402
20.
Clinical outcomes and Oncotype DX Breast Recurrence Score® in early-stage BRCA-associated hormone receptor-positive breast cancer.
Cancer Med
; 11(6): 1474-1483, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35128817